Separate names with a comma.
Nice: Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra® in Lebanon Innovus Eligible to...
Crazy huh? Would have been an excellent bottom play.
Up. BAC -Long ACAD -Long
Future sure looking to keep the spiral in motion Ken. Look out below!!
Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis BEVERLY, Mass., Oct. 31, 2016 (GLOBE...
Data is most impressive. Prospectus supplements issued as well to keep them current. Peer review should be well received imo.
My retirement went to cash in June or July with only my paydays accumulating in the Govt. TSP international, large and small cap funds. In other...
lmao. Another flat day looks like. Things were looking pretty good.
The Company has a compliance period of 180 calendar days, or until February 13, 2017, to regain compliance with Nasdaq’s minimum bid price...
Thanks for your help Gil. I was going to add more info. Waiting on a reply from the company about this weeks presentation to see if they can...
About Us At Amedica, we have the scientific and manufacturing expertise to produce medical grade silicon nitride - a patented platform technology...
No thread on AMDA We'll see soon if it's worth starting one.
Oct-25-16 10:02AM Hertz calls bet on gains by Christmas Oct-24-16 07:13AM Coverage initiated on Hertz Global by Goldman Looks like this is...
LMAO no doubt!!
Going into earnings is always risky. Good luck Baggi!!
ACAD just may start pinching.
Thanks Gil. Thinking it goes for that double bottom. No real reason for this selloff unless they're expecting bad data or very poor #'s from...
And I'm out. lol 24.10 s/l sometimes I just need to learn to kill an idea if it's not working out.
On paper. Long ACAD $24.16. Looking like a sideways channel 23.18 - 25.88. Bio's clearly are still out of favor.
ACAD decidedly will not have its pinch today lol.
